BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 4, Issue 1
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (14151)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.
Item 
Count 
PDF814
WORD390
HTML6524
Figures (1-5)387
Tables (1-1)601
 Sum=8716
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1006
Download1846
 Sum=2852
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1174
Download1409
 Sum=2583
Mar 9, 2015 (publication date) through Apr 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Pharmacology
ISSN
2220-3192
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Cuestas ML, Oubiña JR, Mathet VL. Hepatocellular carcinoma and multidrug resistance: Past, present and new challenges for therapy improvement. World J Pharmacol 2015; 4(1): 96-116 [DOI: 10.5497/wjp.v4.i1.96]
URL: https://www.wjgnet.com/2220-3192/full/v4/i1/96.htm
Number Citing Articles
1
Anhui Yang, Zhen Sun, Rui Liu, Xin Liu, Yue Zhang, Yulin Zhou, Ye Qiu, Xinrui Zhang. Transferrin-Conjugated Erianin-Loaded Liposomes Suppress the Growth of Liver Cancer by Modulating Oxidative Stress. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.727605
2
Madhu Shree Poddar, Yu-De Chu, Chau-Ting Yeh, Cheng-Hsien Liu. Deciphering hepatoma cell resistance to tyrosine kinase inhibitors: insights from a Liver-on-a-Chip model unveiling tumor endothelial cell mechanisms. Lab on a Chip 2024; 24(15): 3668 doi: 10.1039/D4LC00238E
3
Nouf Juaid, Amr Amin, Ali Abdalla, Kevin Reese, Zaenah Alamri, Mohamed Moulay, Suzan Abdu, Nabil Miled. Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights. International Journal of Molecular Sciences 2021; 22(19): 10774 doi: 10.3390/ijms221910774
4
Aswathy R Devan, Keechilat Pavithran, Bhagyalakshmi Nair, Maneesha Murali, Lekshmi R Nath. Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(36): 5250-5264 doi: 10.3748/wjg.v28.i36.5250
5
Tarun Sahu, Arundhati Mehta, Henu Kumar Verma, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 227 doi: 10.1016/B978-0-323-98807-0.00020-X
6
Madhu Shree Poddar, Yu-De Chu, Gaurav Pendharkar, Cheng-Hsien Liu, Chau-Ting Yeh. Exploring cancer-associated fibroblast-induced resistance to tyrosine kinase inhibitors in hepatoma cells using a liver-on-a-chip model. Lab on a Chip 2024; 24(21): 5043 doi: 10.1039/D4LC00624K
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345